Published in J Oncol Pract on November 01, 2005
Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg (1994) 8.85
The sentinel node in breast cancer--a multicenter validation study. N Engl J Med (1998) 8.48
Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med (2002) 7.66
Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol (1993) 4.22
Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol (2000) 3.13
Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol (1999) 2.36
Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst (2003) 2.11
Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg (2003) 2.02
Axillary recurrence after a negative sentinel node biopsy for breast cancer: incidence and clinical significance. Ann Surg Oncol (2005) 1.97
The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg (2004) 1.87
Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer (2005) 1.73
Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg (2003) 1.68
National practice patterns of sentinel lymph node dissection for breast carcinoma. J Am Coll Surg (2001) 1.48
Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol (2003) 1.40
The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer. Ann Surg Oncol (2005) 1.26
Axillary recurrence after sentinel node biopsy. Ann Surg Oncol (2004) 1.20
European studies on breast lymphatic mapping. Semin Oncol (2004) 1.12
Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg (2001) 1.05
Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg (2002) 1.04
Beyond the clinical trials: how often is sentinel lymph node dissection performed for breast cancer? Ann Surg Oncol (2004) 1.01
200 Sentinel lymph node biopsies without axillary lymph node dissection -- no axillary recurrences after a 3-year follow-up. Br J Cancer (2004) 0.99
See one, do twenty-five, teach one: the implementation of sentinel node dissection in breast cancer. Ann Surg Oncol (1999) 0.96
The learning curve and sentinel node biopsy. Am J Surg (2001) 0.83
Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2014) 4.61
Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer (2006) 2.79
Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol (2002) 2.51
American Society of Clinical Oncology policy statement: opportunities in the patient protection and affordable care act to reduce cancer care disparities. J Clin Oncol (2011) 2.30
Predictors of re-excision among women undergoing breast-conserving surgery for cancer. Ann Surg Oncol (2008) 2.14
Breast cancer in sub-Saharan Africa: how does it relate to breast cancer in African-American women? Cancer (2005) 2.05
Perceptions of clinical research participation among African American women. J Womens Health (Larchmt) (2007) 1.86
Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation. Head Neck (2003) 1.79
Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node. Ann Surg Oncol (2006) 1.75
A midpoint assessment of the American Cancer Society challenge goal to halve the U.S. cancer mortality rates between the years 1990 and 2015. Cancer (2006) 1.73
Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer (2002) 1.69
Higher population-based incidence rates of triple-negative breast cancer among young African-American women : Implications for breast cancer screening recommendations. Cancer (2011) 1.59
Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. J Clin Oncol (2008) 1.42
Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation. Head Neck (2006) 1.40
Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg (2005) 1.39
Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat (2005) 1.30
Small (< or = 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology (2004) 1.29
Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol (2007) 1.21
The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer (2004) 1.18
Management of patients with locally advanced breast cancer. Surg Clin North Am (2007) 1.17
Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer center. Breast J (2009) 1.14
Assessing breast cancer risk: evolution of the Gail Model. J Natl Cancer Inst (2006) 1.13
A midpoint assessment of the American Cancer Society challenge goal to decrease cancer incidence by 25% between 1992 and 2015. CA Cancer J Clin (2007) 1.12
Effect of esthetic outcome after breast-conserving surgery on psychosocial functioning and quality of life. J Clin Oncol (2008) 1.12
Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram? Ann Surg Oncol (2005) 1.11
Breast cancer risk assessment models: applicability to African-American women. Cancer (2003) 1.09
Residual disease after re-excision lumpectomy for close margins. J Surg Oncol (2009) 1.08
Complications in breast surgery. Surg Clin North Am (2007) 1.07
Lymphatic mapping techniques and sentinel lymph node biopsy in breast cancer. Surg Clin North Am (2007) 1.04
Sentinel lymph node biopsy for breast cancer: how many nodes are enough? J Surg Oncol (2007) 1.04
Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women. Cancer (2012) 1.03
Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy. J Clin Oncol (2011) 1.02
Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol (2002) 1.02
Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer (2003) 1.00
Development of an intraoperative pathology consultation service at a free-standing ambulatory surgical center: clinical and economic impact for patients undergoing breast cancer surgery. Am J Surg (2011) 0.99
Pregnancy-associated breast cancer: a literature review. Surg Clin North Am (2007) 0.99
Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer. Am J Surg (2005) 0.96
Eating ability in head and neck cancer patients after treatment with chemoradiation: a 12-month follow-up study accounting for dropout. Head Neck (2003) 0.95
Sixty years of CA: a cancer journal for clinicians. CA Cancer J Clin (2010) 0.95
Effects of enhanced bolus flavors on oropharyngeal swallow in patients treated for head and neck cancer. Head Neck (2012) 0.94
Correlates of patient satisfaction and provider trust after breast-conserving surgery. Cancer (2008) 0.94
Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy. Ann Surg Oncol (2006) 0.89
Radiofrequency ablation of early-stage invasive breast tumors: an overview. Cancer J (2002) 0.89
A Diet and Exercise Intervention during Chemotherapy for Breast Cancer. Open Obes J (2011) 0.89
CAGS and ACS evidence based reviews in surgery. 48. What is the effect of screening mammography on breast cancer incidence? Can J Surg (2014) 0.88
Investigating the phenotypes and genotypes of breast cancer in women with African ancestry: the need for more genetic epidemiology. Surg Clin North Am (2007) 0.88
Predictors of breast asymmetry after breast-conserving operation for breast cancer. J Am Coll Surg (2007) 0.87
Diagnosis and management of ductal carcinoma in situ. Curr Treat Options Oncol (2004) 0.87
Lymphatic mapping and sentinel lymph node biopsy for breast cancer: developments and resolving controversies. J Clin Oncol (2005) 0.86
When is age more than just a number? Ann Surg Oncol (2010) 0.85
Cancer clinical trials accrual: missed opportunities to address disparities and missed opportunities to improve outcomes for all. Ann Surg Oncol (2008) 0.85
Neoadjuvant docetaxel and capecitabine and the use of thymidine phosphorylase as a predictive biomarker in breast cancer. Clin Cancer Res (2007) 0.85
Invasive breast carcinomas in Ghana: high frequency of high grade, basal-like histology and high EZH2 expression. Breast Cancer Res Treat (2012) 0.84
Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy. Ann Surg Oncol (2005) 0.84
Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrence. Ann Surg Oncol (2008) 0.84
Neoadjuvant systemic therapy and the surgical management of breast cancer. Surg Clin North Am (2007) 0.84
Beyond efficacy and effectiveness: conducting economic analyses during clinical trials. Dysphagia (2004) 0.83
Features associated with successful recruitment of diverse patients onto cancer clinical trials: report from the American College of Surgeons Oncology Group. Ann Surg Oncol (2011) 0.83
Is duct excision still necessary for all cases of suspicious nipple discharge? Breast J (2011) 0.82
Efficacy of sentinel lymph node biopsy in male breast cancer. J Surg Oncol (2004) 0.82
Guide for investigators conducting international cancer research involving developing nations. Cancer (2010) 0.82
Breast carcinoma in African-American and White women: application of molecular biology to understand outcome disparities. Cancer (2004) 0.81
Breast-conservation therapy in early-stage breast cancer patients with a positive family history. Ann Surg Oncol (2002) 0.81
Mastectomy and concomitant sentinel lymph node biopsy for invasive breast cancer. Am J Surg (2004) 0.80
Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy. Cancer (2008) 0.79
Locoregional control of breast cancer: surgical technique does matter. Ann Surg Oncol (2004) 0.79
Controversies in breast surgery. Ann Surg Oncol (2010) 0.77
Does the method of biopsy affect the incidence of sentinel lymph node metastases? Breast J (2006) 0.76
Ductal lavage for breast cancer risk assessment. Surg Oncol Clin N Am (2005) 0.76
The Komen Foundation: ACS Outreach Collaboration-Sentinel Lymph Node Biopsy Training for Practicing Surgeons in Remote or Underserved Communities. J Oncol Pract (2006) 0.75
The search for occult metastatic disease in breast cancer patients: how far should we go? Ann Surg Oncol (2006) 0.75
Sentinel lymph node biopsy for breast cancer: will variations in technique influence long-term outcome? Ann Surg Oncol (2005) 0.75
Understanding the reasonable, but limited benefits of the CPM strategy. Ann Surg (2011) 0.75
Surgical breast oncologists: successful innovators and patient advocates. Oncology (Williston Park) (2014) 0.75
Lymphatic mapping and sentinel lymph node biopsy for locally recurrent breast cancer: new clues to understanding the biology of chest wall relapse. Ann Surg Oncol (2007) 0.75
Minimally invasive operation for breast cancer. Curr Probl Surg (2004) 0.75
The role of speech-language pathology and audiology in the optimal management of the service member returning from Iraq or Afghanistan with a blast-related head injury: position of the Communication Sciences and Disorders Clinical Trials Research Group. J Head Trauma Rehabil (2010) 0.75
Decision Making in the Surgical Management of Invasive Breast Cancer-Part 1: Lumpectomy, Mastectomy, and Contralateral Prophylactic Mastectomy. Oncology (Williston Park) (2017) 0.75
Global surgical oncology disease burden: addressing disparities via global surgery initiatives: the University of Michigan International Breast Cancer Registry. Ann Surg Oncol (2015) 0.75
An academic health center cost analysis of screening mammography: creating a financially viable service. Cancer (2004) 0.75
An Analysis of the Decisions Made for Contralateral Prophylactic Mastectomy and Breast Reconstruction. Plast Reconstr Surg (2016) 0.75
Decision Making in the Surgical Management of Invasive Breast Cancer-Part 2: Expanded Applications for Breast-Conserving Surgery. Oncology (Williston Park) (2017) 0.75